Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: Prospective randomized double-masked study

Journal of Cataract and Refractive Surgery

Volumn 28, Issue 1, 2002, Pages 93-99

  Holzer, Mike P ^a   Solomon, Kerry D ^a   Sandoval, Helga P ^a   Vroman, David T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETOROLAC TROMETAMOL; LOTEPREDNOL ETABONATE; OFLOXACIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE INFLAMMATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLIT LAMP; TREATMENT OUTCOME;

AGED; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; FEMALE; FOREIGN-BODY REACTION; HUMANS; INTRAOCULAR PRESSURE; KETOROLAC TROMETHAMINE; LENS IMPLANTATION, INTRAOCULAR; MALE; OPHTHALMIC SOLUTIONS; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SAFETY; TREATMENT OUTCOME; UVEITIS, ANTERIOR;

EID: 0036140991     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(01)01185-3     Document Type: Article

References (30)

1. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial
2. The effect of ketorolac tromethamine solution 0.5% in reducing postoperative inflammation after cataract extraction and intraocular lens implantation
3. Corticoides at ophtalmologie
4. Steroids and the eye - Indications and complications
5. Topical nonsteroidal anti-inflammatory agents in ophthalmology
6. Control of intra-ocular inflammation associated with cataract surgery
7. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery
8. The effect of ketorolac tromethamine in reducing postoperative inflammation: Double-mask parallel comparison with dexamethasone
9. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema
10. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells
11. Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery
12. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction; prospective randomized double-masked study
13. Prophylaxis of aphakic cystoid macular edema without corticosteroids; a paired-comparison, placebo-controlled double-masked study
14. Efficacy of diclofenac sodium solution in reducing discomfort after cataract surgery
15. Corneal wound healing strength with topical antiinflammatory drugs
16. Topical diclofenac following excimer laser: Effect on corneal sensitivity and wound healing in rabbits
17. Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy
18. The effect of preoperative topical flurbiprofen or diclofenac on pupil dilatation
19. Topical 0.5% ketorolac vs 0.03% flurbiprofen for inhibition of miosis during cataract surgery
20. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery
21. New corticosteroids for the treatment of ocular inflammation
22. Ocular therapeutics and drug delivery: An overview
23. A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits
24. Change in intraocular pressure during long-term use of loteprednol etabonate
25. Reproducibility and validity of laser flare/cell meter measurements of intraocular inflammation
26. Reproducibility and validity of laser flare/cell meter measurements as an objective method of assessing intraocular inflammation
27. Loteprednol etabonate: A review of ophthalmic clinical studies
28. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs
29. Effects of topical ketorolac and diclofenac on normal corneal sensation
30. Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs